Can CYP Inhibition Overcome Chemotherapy Resistance?
anticancer drug resistance
cytochrome P450
enzyme induction
hepatocellular carcinoma
Journal
Trends in pharmacological sciences
ISSN: 1873-3735
Titre abrégé: Trends Pharmacol Sci
Pays: England
ID NLM: 7906158
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
31
05
2020
accepted:
31
05
2020
pubmed:
24
6
2020
medline:
1
9
2021
entrez:
24
6
2020
Statut:
ppublish
Résumé
A 2016 study proposed induction of the cytochrome P450 (CYP) enzyme CYP3A5 as a key mechanism for chemotherapy resistance and suggested CYP3A5 as a promising therapeutic target. However, in the context of the available literature we are skeptical that CYP3A5 contributes significantly to cancer drug resistance.
Identifiants
pubmed: 32571525
pii: S0165-6147(20)30136-X
doi: 10.1016/j.tips.2020.05.007
pii:
doi:
Substances chimiques
Cytochrome P-450 Enzyme System
9035-51-2
Types de publication
Letter
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
503-506Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.